These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 14760258

  • 1. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants.
    Clark HF, Bernstein DI, Dennehy PH, Offit P, Pichichero M, Treanor J, Ward RL, Krah DL, Shaw A, Dallas MJ, Laura D, Eiden JJ, Ivanoff N, Kaplan KM, Heaton P.
    J Pediatr; 2004 Feb; 144(2):184-90. PubMed ID: 14760258
    [Abstract] [Full Text] [Related]

  • 2. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.
    Vesikari T, Clark HF, Offit PA, Dallas MJ, DiStefano DJ, Goveia MG, Ward RL, Schödel F, Karvonen A, Drummond JE, DiNubile MJ, Heaton PM.
    Vaccine; 2006 May 29; 24(22):4821-9. PubMed ID: 16621194
    [Abstract] [Full Text] [Related]

  • 3. Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life.
    Block SL, Vesikari T, Goveia MG, Rivers SB, Adeyi BA, Dallas MJ, Bauder J, Boslego JW, Heaton PM, Pentavalent Rotavirus Vaccine Dose Confirmation Efficacy Study Group.
    Pediatrics; 2007 Jan 29; 119(1):11-8. PubMed ID: 17200266
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
    Ruiz-Palacios GM, Guerrero ML, Bautista-Márquez A, Ortega-Gallegos H, Tuz-Dzib F, Reyes-González L, Rosales-Pedraza G, Martínez-López J, Castañón-Acosta E, Cervantes Y, Costa-Clemens S, DeVos B.
    Pediatrics; 2007 Aug 29; 120(2):e253-61. PubMed ID: 17606534
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The integrated phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine.
    Dennehy PH, Goveia MG, Dallas MJ, Heaton PM.
    Int J Infect Dis; 2007 Nov 29; 11 Suppl 2():S36-42. PubMed ID: 18162245
    [Abstract] [Full Text] [Related]

  • 12. The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants.
    Clark HF, Offit PA, Plotkin SA, Heaton PM.
    Pediatr Infect Dis J; 2006 Jul 29; 25(7):577-83. PubMed ID: 16804425
    [Abstract] [Full Text] [Related]

  • 13. Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq.
    Ciarlet M, Schödel F.
    Vaccine; 2009 Dec 30; 27 Suppl 6():G72-81. PubMed ID: 20006144
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine.
    Ciarlet M, Sani-Grosso R, Yuan G, Liu GF, Heaton PM, Gottesdiener KM, Arredondo JL, Schödel F.
    Pediatr Infect Dis J; 2008 Oct 30; 27(10):874-80. PubMed ID: 18756184
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritis.
    Heaton PM, Goveia MG, Miller JM, Offit P, Clark HF.
    J Infect Dis; 2005 Sep 01; 192 Suppl 1():S17-21. PubMed ID: 16088800
    [Abstract] [Full Text] [Related]

  • 18. Concomitant use of an oral live pentavalent human-bovine reassortant rotavirus vaccine with licensed parenteral pediatric vaccines in the United States.
    Rodriguez ZM, Goveia MG, Stek JE, Dallas MJ, Boslego JW, DiNubile MJ, Heaton PM.
    Pediatr Infect Dis J; 2007 Mar 01; 26(3):221-7. PubMed ID: 17484218
    [Abstract] [Full Text] [Related]

  • 19. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group.
    Rennels MB, Wasserman SS, Glass RI, Keane VA.
    Pediatrics; 1995 Dec 01; 96(6):1132-6. PubMed ID: 7491235
    [Abstract] [Full Text] [Related]

  • 20. A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial.
    Bhandari N, Sharma P, Taneja S, Kumar T, Rongsen-Chandola T, Appaiahgari MB, Mishra A, Singh S, Vrati S, Rotavirus Vaccine Development Group.
    J Infect Dis; 2009 Aug 01; 200(3):421-9. PubMed ID: 19545211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.